申请人:Lu Qing-Bin
公开号:US10463662B2
公开(公告)日:2019-11-05
Disclosed herein are non-platinum-based (NPB) anti-cancer compounds useful for targeted chemotherapy, e.g., to generate anti-cancer effects for the treatment of cancer and other disorders while having no or minimal toxicity. The compounds N have the general formula I: (I) wherein A represents an aromatic core; at least one of Ra and Rb is an electron transfer promoter as defined herein, e.g., NH2; and at least one of Rc is a leaving group as defined herein, e.g., halogen; and the remainder of the molecule is as defined herein. Pharmaceutical compositions, methods, uses, kits and commercial packages comprising the anti-cancer compounds are also disclosed.
本文公开的是非铂基(NPB)抗癌化合物,可用于靶向化疗,例如,产生抗癌效果以治疗癌症和其他疾病,同时无毒性或毒性最小。化合物 N 具有通式 I:(I) 其中 A 代表芳香族核心;Ra 和 Rb 中至少一个是本文定义的电子转移促进剂,如 NH2;Rc 中至少一个是本文定义的离去基团,如卤素;分子的其余部分如本文定义。还公开了包含抗癌化合物的药物组合物、方法、用途、试剂盒和商业包装。